Stay informed with the latest updates for the inheritable blood disorders community. Industry Trial Results for Investigational Glanzmann Thrombasthenia…Dec 12, 2025 Industry Five Year Hemgenix® Hemophilia B Trial Data Published in NEJMDec 10, 2025 Industry Interim Data for Investigational Sub-Q VWD Therapy Presented at ASHDec 9, 2025 Industry BioMarin Announces ROCTAVIAN Out-Licensing Plans for Hemophilia A Therapy…Oct 31, 2025 Industry Star Therapeutics Announces New Financing for Investigational VWD…Oct 2, 2025 Industry Novo Submits New Application for Its Investigational SubQ Hemophilia…Sep 30, 2025 Industry New Approval Expands Indication for Recombinant VWD TherapySep 8, 2025 Industry Be Biopharma Announces First Hemophilia Patient Dosed with New Cell…Jul 30, 2025 Industry New Trial Data Suggests Oral ITP Therapy Effective in Children and…Jul 25, 2025 Industry Pfizer Announces Phase 3 Trial Results for Hemophilia/Inhibitor TherapyJul 16, 2025 Industry Investigational Data on VWD and Glanzmann Thrombasthenia…Jul 2, 2025 Industry Trial Data for Roche Investigational SubQ Hemophilia Therapy Presented…Jun 26, 2025 Industry Integration of Spark into Roche Group Set, Hemophilia Gene…Jun 9, 2025 Industry Breaking News: Takeda Announces Discontinuation of Two Hemophilia…Mar 18, 2025 Industry First Patient Dosed with Investigational Sub-Q Therapy for von…Mar 5, 2025 Pagination First page Previous page Current page 1 Page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Next page Last page